3 ms·

Meow-1: Biopharmaceutical Company Is Testing Weight Loss Drug for Cats

• randycupertino 9mo ago
  > According to a report in ABC News, a landmark new study called MEOW-1 is being launched by San Francisco-based biopharmaceutical company Okava to test a GLP-1 medication on up to 50 overweight cats. A miniature implant, labeled OKV-119, will administer GLP-1 medication to cats in this study continuously for up to six months. > Okava CEO Michael Klotsman claims the company will seek FDA approval for the product between 2027 and 2028.